Natural Capsules Board Approves Financial Results & Preferential Issue of Warrants
Natural Capsules approved Q1 FY27 results and a preferential issue of equity shares and warrants worth ₹2 crore and ₹8 crore respectively, at ₹160 per share to the promoter group. An EGM is scheduled for September 9, 2026.
The preferential issue of equity shares and warrants can dilute existing shareholding but also provides capital. The approval of financial results is routine but important for investors.
The company approved financial results and a preferential issue which is a form of equity fundraising, indicating positive corporate actions.
Natural Capsules Limited announced the outcome of its Board Meeting held on August 12, 2026. The Board approved the Unaudited Consolidated & Standalone Financial Results for the quarter ended June 30, 2026.
Additionally, the company approved a preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to the promoter/promoter group. The issue price for both equity shares and warrants (convertible into equity shares) is fixed at ₹160 per share. The equity shares will aggregate to ₹2 crore and warrants to ₹8 crore. A minimum of 25% of the warrant issue price (₹40 per warrant) is to be paid at the time of subscription. The issuance is subject to shareholder and regulatory approvals.
The Board also approved the draft notice for an Extra Ordinary General Meeting (EGM) to be held on September 9, 2026, and appointed M/S Deepak Sadhu, Practicing Company Secretaries, as the scrutinizer for the e-voting process. The Board meeting commenced at 3:30 PM and concluded at 6:00 PM.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.